Literature DB >> 1784009

Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis.

R J Behme1, D Brooke.   

Abstract

Two polymorphs of carbamazepine that melt at 176 and 189 degrees C and are known to be enantiotropic have been characterized more fully than in previous reports. For the first time, a value for the heat of fusion (29.3 kJ/mol) of the lower melting form is estimated, even though single melting DSC endotherms were not obtained. A method is described for summing the heat flows of intermediate transitions that occur when low melting carbamazepine is heated to a temperature where it will remain melted. The method should have general applicability in studies of polymorphs. Other characteristics of the carbamazepine enantiotropic pair are reported, including the transition temperature (71 degrees C).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1784009     DOI: 10.1002/jps.2600801016

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Crystal doping aided by rapid expansion of supercritical solutions.

Authors:  Chandra Vemavarapu; Matthew J Mollan; Thomas E Needham
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

3.  A quantitative model to evaluate solubility relationship of polymorphs from their thermal properties.

Authors:  Chen Mao; Rodolfo Pinal; Kenneth R Morris
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

4.  Cocrystal formation during cogrinding and storage is mediated by amorphous phase.

Authors:  Adivaraha Jayasankar; Anongnat Somwangthanaroj; Zezhi J Shao; Naír Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2006-09-19       Impact factor: 4.200

5.  Miniaturized assay for solubility and residual solid screening (SORESOS) in early drug development.

Authors:  Nicole Wyttenbach; Jochem Alsenz; Olaf Grassmann
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

6.  Polymorphic Phase Transitions in Carbamazepine and 10,11-Dihydrocarbamazepine.

Authors:  Alexander E Clout; Asma B M Buanz; Simon Gaisford; Gareth R Williams
Journal:  Chemistry       Date:  2018-08-20       Impact factor: 5.236

7.  Stability of Pharmaceutical Co-Crystals at Humid Conditions Can Be Predicted.

Authors:  Heiner Veith; Maximilian Zaeh; Christian Luebbert; Naír Rodríguez-Hornedo; Gabriele Sadowski
Journal:  Pharmaceutics       Date:  2021-03-23       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.